This report is an effort to identify factors, which will be the driving force
for the infertility drugs and devices market and sub-markets in the next few
years. The report provides an extensive analysis of the industry, current
market trends, industry drivers and challenges for better understanding of the
market structure. The report segregates the infertility drugs and devices
industry in terms of products, technology and geography. We have used a
combination of primary and secondary research to arrive at the market
estimates, market shares and trends. We have adopted bottom up model to derive
market size of the global infertility drugs and devices market and further
validated numbers with the key market participants and C-level executives.
This report highlights the industry with the following points:
Definition, estimates and forecast of infertility drugs and devices market
from 2010 to 2017
Analysis of product segments for infertility drugs and devices market with
historical data and forecast
Trends and forecast for four geographic markets, namely North America,
Europe, Asia Pacific and the RoW regions based on segments of infertility
drugs and devices market
Profiles of major market participants for better understanding of their
contributions
This research is specially designed to estimate and analyze the demand and
performance of infertility drugs and devices in a global scenario. The
research provides in-depth analysis of infertility drugs and devices
manufacturers, product sales, trend analysis by segments and demand by
geography. The report covers all the major product segments of the global
infertility drugs and devices market and provide in-depth analysis, historical
data and statistically refined forecast for the segments covered. The study
presents a comprehensive assessment of the stakeholder strategies and winning
imperatives for them by segmenting the global infertility drugs and devices
market as below:
Infertility Drugs and Devices Market by Types
Female
Endometriosis
Ovarian Disorders
Uterine Disorders
Tubal Disorders
Hormonal Disorders
Male
Azoospermia
Varicocele
Ejaculation Disorder
Erectile Dysfunction
Infertility Drugs and Devices by Technology
Assisted Reproductive Technologies
In Vitro Fertilization
Artificial Insemination
Surgery
Infertility Drugs and Devices Market by Geography
Europe Infertility Drugs and Devices Market
U.K
France
Germany
Italy
Spain
North America Infertility Drugs And Devices Market
U.S
Canada
Mexico
Asia Pacific Infertility Drugs And Devices Market
Japan
India
China
Row Infertility Drugs And Devices Market
Brazil's
The in-depth research and high level analysis will allow infertility drugs and
device manufacturers, lawmakers, large retailers, medical companies and
research and development agencies to make informed decisions about infertility
drugs and devices manufacturing, designing marketing, growth strategies and
gaining competitive advantage.
About Transparency Market Research
Transparency Market Research is a market intelligence company providing,
global business research reports and consulting services. Our exclusive blend
of quantitative forecasting and trends analysis provides forward-looking
insights for thousands of decision-makers. Our experienced team of analysts,
researchers, and consultants use proprietary data sources along with various
tools and techniques to gather and analyze information. Our business offerings
represent the latest and the most reliable information which is indispensable
for businesses to sustain their competitive edge.
Our data repository is continuously updated and revised by a team of research
experts so that it always reflects the latest trends and information. With a
broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.
Table of Contents
Table of Contents
CHAPTER 1 - PREFACE
1.1 KEY POINTS COVERED
1.2 REPORT DESCRIPTION
1.3 RESEARCH METHODOLOGY
CHAPTER 2 - EXECUTIVE SUMMARY AND MARKET OVERVIEW
CHAPTER 3 - INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS
3.1. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND)
AND ANNUAL GROWTH RATE, 2010 - 2017
3.1.1. COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES
MARKET, 2010 V/S 2017
3.1.2. GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 - 2017
GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 - 2017
3.2. POPULATION GROWTH TREND
3.2.1. GLOBAL MALE AND FEMALE POPULATION GROWTH TREND BY AGE GROUP
3.2.2. INFERTILITY DRUGS AND DEVICES MARKET ATTRACTIVENESS ANALYSIS BY
GEOGRAPHY
3.3. CAUSES OF INFERTILITY
3.4. MARKET DYNAMICS
3.4.1. DRIVERS
3.4.1.1. Rising number of infertile people
3.4.1.2. Increasing worldwide obesity
3.4.1.3. Rising disposable incomes of the consumers
3.4.1.4. Lifestyle hazards such as rising number of smokers, stress
and pollution
3.4.1.5. Adoption of babies by homosexual couples
3.4.1.6. Availability of government support for infertility abatement
procedures
3.4.2. INFERTILITY DRUGS AND DEVICES MARKET DRIVER IMPACT ANALYSIS
3.4.3. RESTRAINTS
3.4.3.1. Limited insurance covers
3.4.3.2. Religious bans on artificial insemination procedures
especially the Islamic bans
3.4.3.3. Risk of repeat procedures
3.4.3.4. Traditional infertility treatments such as the Chinese
infertility treatments
3.4.3.5. Ban on artificial reproduction procedures in European
countries especially Turkey, Germany, Italy and France
3.4.3.6. Patent expiration of infertility drugs
3.4.4. INFERTILITY DRUGS AND DEVICES MARKET RESTRAINTS IMPACT ANALYSIS
3.4.5. OPPORTUNITY
3.4.5.1. Technological advancements in the Asia Pacific region and the
developmental activities in the region
3.4.5.2. Medical tourism initiatives in the developing countries
3.4.5.3. Need for more ART cycles
3.1. MARKET SHARE ANALYSIS, 2011
3.2. PORTER'S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES
MARKET
3.2.1. BARGAINING POWER OF SUPPLIERS
3.2.1. BARGAINING POWER OF BUYERS
3.2.2. THREAT OF NEW ENTRANTS
3.2.3. THREAT OF SUBSTITUTES
3.2.4. COMPETITIVE RIVALRY
CHAPTER 4 - INFERTILITY DRUGS AND DEVICES MARKET SEGMENTATION
4.1. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY TYPES
4.1.1. FEMALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.1.1. Global Infertility drugs and devices market by Endometriosis
female infertility types
4.1.1.2. Global Infertility drugs and devices market by Ovarian
disorder female infertility types
4.1.1.3. Global Infertility drugs and devices market by Uterine
disorder female infertility types
4.1.1.4. Global Infertility drugs and devices market by Tubal disorder
female infertility types
4.1.1.5. Global Infertility drugs and devices market by Hormonal
disorder female infertility types
4.1.2. MALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.2.1. Global Infertility drugs and devices market by Azoospermia
male infertility types
4.1.2.2. Global Infertility drugs and devices market by Varicocele
male infertility types
4.1.2.3. Global Infertility drugs and devices market by Ejaculation
Disorder male infertility types
4.1.2.4. Global Infertility drugs and devices market by Erectile
Dysfunction male infertility types
4.2. INFERTILITY DRUGS AND DEVICES MARKET BY TECHNOLOGY
4.2.1. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL
INSEMINATION
4.2.2. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ASSISTED
REPRODUCTIVE TECHNOLOGIES (USD THOUSAND)
4.2.3. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY IN VITRO
FERTILIZATION (USD THOUSAND)
4.2.4. GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY SURGERY (USD
THOUSAND) 57
CHAPTER 5 - REGION-WISE ANALYSIS
5.1. INFERTILITY DRUGS AND DEVICES MARKET BY REGION
5.1.1. EUROPE INFERTILITY DRUGS AND DEVICES MARKET
5.1.1.1. U.K
5.1.1.2. France
5.1.1.3. Germany
5.1.1.4. Italy
5.1.1.5. Spain
5.1.2. NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3. NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3.1. U.S
5.1.3.2. CANADA
5.1.3.3. MEXICO
5.1.4. ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5. ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5.1. Japan
5.1.5.2. India
5.1.5.3. China
5.1.6. ROW INFERTILITY DRUGS AND DEVICES MARKET
5.1.7. ROW INFERTILITY DRUGS AND DEVICES MARKET
5.1.7.1. Brazil's Infertility drugs and devices market
CHAPTER 6 - COMPANY PROFILES
6.1. JOHNSON & JOHNSON
6.1.1. COMPANY OVERVIEW
6.1.2. FINANCIAL OVERVIEW
6.1.3. BUSINESS STRATEGIES
6.1.4. RECENT DEVELOPMENTS
6.2. MERCK
6.2.1. COMPANY OVERVIEW
6.2.2. FINANCIAL OVERVIEW
6.2.3. BUSINESS STRATEGIES
6.2.4. PRODUCT PORTFOLIO
6.2.5. RECENT DEVELOPMENT
6.3. TEVA PHARMACEUTICALS
6.3.1. COMPANY OVERVIEW
6.3.2. FINANCIAL OVERVIEW
6.3.3. BUSINESS STRATEGIES
6.3.4. PRODUCT PORTFOLIO
6.3.5. RECENT DEVELOPMENTS
6.4. ORIGIO
6.4.1. COMPANY OVERVIEW
6.4.2. FINANCIAL OVERVIEW
6.4.3. BUSINESS STRATEGIES
6.4.4. PRODUCT PORTFOLIO
6.4.5. RECENT DEVELOPMENTS
6.5. BAYER
6.5.1. COMPANY OVERVIEW
6.5.2. FINANCIAL OVERVIEW
6.5.3. BUSINESS STRATEGIES
6.5.4. PRODUCT PORTFOLIO
6.5.5. RECENT DEVELOPMENT
LIST OF FIGURES
FIG. 1: GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND)
AND ANNUAL GROWTH RATE, 2010 - 2017 (%)
FIG. 2: COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES
MARKET SHARE, 2010 VS 2017
TABLE 74: ROW FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 -
2017 (THOUSAND )
TABLE 75: ROW INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL
INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
TABLE 76: BRAZIL INFERTILITY DRUGS AND DEVICES MARKET, 2010 - 2017 (USD
THOUSAND)
TABLE 77: BRAZIL POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND)
TABLE 78: BRAZIL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017
(THOUSAND)
TABLE 79: BRAZIL FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED,
2010 - 2017 (THOUSAND )
TABLE 80: BRAZIL INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE
BY FERTILITY TYPE, 2010 - 2017 (USD THOUSAND )
TABLE 81: BRAZIL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL
INSEMINATION TECHNOLOGY, 2010 - 2017 (USD THOUSAND )
Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017 published by Transparency Market Research in November 17, 2012. This report consists of 130 Pages and the price starts from US $ 4395.
